Article Text

Download PDFPDF
Oculometric alterations following intravitreal triamcinolone injection
  1. Osman Çekiç,
  2. Yavuz Bardak
  1. Department of Ophthalmology, SDU Medical School, Isparta, Turkey
  1. Correspondence to Dr Osman Çekiç, Department of Ophthalmology, Vakif Gureba Training Hospital, Fatih, Istanbul, Turkey; ocekic{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Intravitreal steroids have been used extensively for the treatment of various intraocular disorders, such as macular oedema due to retinal vein occlusion,1 2 diabetes mellitus3 and choroidal neovascularisation.4 We investigated prospectively the early effects of intravitreal triamcinolone injection on biometric, pachymetric, refractive and keratometric measurements of the globe.

Twenty-four phakic eyes of 16 patients (nine male, seven female) received a 0.1 ml (4 mg) intravitreal dose of triamcinolone acetonide through pars plana for macular oedema with branch retinal vein occlusion (n=12), central retinal vein occlusion (n=11) and hemiretinal vein occlusion (n=1).

Patients underwent measurements of total axial length (AL), lens thickness (LT), anterior chamber depth (ACD), vitreous depth (VD), central corneal thickness (CCT), refractive index of cornea and objective refractometry before and 1 and 7 days …

View Full Text


  • Competing interests None to declare.

  • Patient consent Obtained.

  • Ethics approval This study was conducted with the approval of the Suleyman Demirel University Medical School, Isparta, Turkey.

  • Provenance and peer review Not commissioned; externally peer reviewed.